Literature DB >> 24615893

Triggered liposomal release through a synthetic phosphatidylcholine analogue bearing a photocleavable moiety embedded within the sn-2 acyl chain.

Andrew M Bayer1, Shahrina Alam, Samuel I Mattern-Schain, Michael D Best.   

Abstract

Liposomes represent promising carriers for drug delivery applications. To maximize this potential, there has been significant interest in developing liposomal systems encapsulating molecular cargo that are highly stable until their contents are released remotely in a controlled manner. Herein, we describe the design, synthesis, and analysis of a photocleavable analogue of the ubiquitous lipid phosphoatidylcholine (PC) for the development of highly stable and controllable photodisruptable membranes. Our strategy was to develop a lipid that closely mimics the structure of PC to optimize favorable properties including biocompatibility and stability of subsequent liposomes when mixed with lipids possessing a broad range of physicochemical properties. Thus, NB-PC was designed, which contains a photocleavable 2-nitrobenzyl group embedded within the acyl chain at the sn-2 position. Following the synthesis of NB-PC, liposome disruption efficacy was evaluated through photolysis studies involving the detection of nile red release. Studies performed using a range of liposomes with different percentages of NB-PC, PC, phosphatidylethanolamine (PE), cholesterol, and polyethylene glycol-PE (PEG-PE) demonstrated minimal background release in controls, release efficacies that correlate directly with the amount of NB-PC incorporation, and that release is only minimally impacted by the inclusion of the lipids PE and cholesterol that possess disparate properties. These results demonstrate that the NB-PC system is a highly stable, flexible, and tunable system for photoinitiated release from liposomal systems.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  controlled release; drug delivery; lipids; membranes; photocleavage

Mesh:

Substances:

Year:  2014        PMID: 24615893     DOI: 10.1002/chem.201304094

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

1.  A clickable and photocleavable lipid analogue for cell membrane delivery and release.

Authors:  Shahrina Alam; Daiane S Alves; Stuart A Whitehead; Andrew M Bayer; Christopher D McNitt; Vladimir V Popik; Francisco N Barrera; Michael D Best
Journal:  Bioconjug Chem       Date:  2015-05-15       Impact factor: 4.774

2.  Boronic acid liposomes for cellular delivery and content release driven by carbohydrate binding.

Authors:  Xiaoyu Zhang; Daiane S Alves; Jinchao Lou; Shelby D Hill; Francisco N Barrera; Michael D Best
Journal:  Chem Commun (Camb)       Date:  2018-06-12       Impact factor: 6.222

Review 3.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

4.  Mechanisms of Light-induced Liposome Permeabilization.

Authors:  Dyego Miranda; Jonathan F Lovell
Journal:  Bioeng Transl Med       Date:  2016-09-28

Review 5.  Stimuli-Responsive Materials for Tissue Engineering and Drug Delivery.

Authors:  Sofia Municoy; María I Álvarez Echazú; Pablo E Antezana; Juan M Galdopórpora; Christian Olivetti; Andrea M Mebert; María L Foglia; María V Tuttolomondo; Gisela S Alvarez; John G Hardy; Martin F Desimone
Journal:  Int J Mol Sci       Date:  2020-07-02       Impact factor: 5.923

6.  Liposomes formed from photo-cleavable phospholipids: in situ formation and photo-induced enhancement in permeability.

Authors:  Dawei Zhang; Zhenzhen Liu; Danielle Konetski; Chen Wang; Brady T Worrell; Christopher N Bowman
Journal:  RSC Adv       Date:  2018-04-18       Impact factor: 4.036

Review 7.  State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.

Authors:  Elmira Heidarli; Simin Dadashzadeh; Azadeh Haeri
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.